Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Abnormalities, Drug-Induced

medroxyprogesterone acetate has been researched along with Abnormalities, Drug-Induced in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-199013 (81.25)18.7374
1990's0 (0.00)18.2507
2000's2 (12.50)29.6817
2010's0 (0.00)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Dhaliwal, SS; Hinchliffe, PM; Keane, KN; Mariappen, U; Yovich, JL1
BURSTEIN, R; WASSERMAN, HC1
Bakry, S; Fadiel, A; Mahmoud, MS; Merhi, ZO; Naftolin, F; Scalise, TJ1
Dahlberg, K1
Barlow, SM; Knight, AF1
Revaz, C1
Minkin, S1
Eibs, HG; Hägele, M; Spielmann, H1
Chandacham, A; Gray, RH; McDaniel, EB; Pardthaisong, T1
Carroad, E; Cukierski, M; Hendrickx, AG; Prahalada, S1
Carroad, E; Hendrickx, AG; Prahalada, S1
Keller, PJ1
Marks, TA1
Chemke, J; Katz, Z; Klinberg, M; Lancet, M; Mogilner, BM; Skornik, J1
Grauaug, AA; Hollingsworth, P; Lunay, GG; Mulcahy, MT; Stanger, JD; Yovich, JL1

Reviews

2 review(s) available for medroxyprogesterone acetate and Abnormalities, Drug-Induced

ArticleYear
Depot-medroxyprogesterone acetate: an update.
    Archives of gynecology and obstetrics, 2008, Volume: 278, Issue:1

    Topics: Abnormalities, Drug-Induced; Anemia, Sickle Cell; Animals; Arachnoiditis; Body Weight; Bone Density; Contraceptive Agents, Female; Female; Humans; Hypertension; Lactation; Lipoproteins; Liver; Medroxyprogesterone Acetate; Neoplasms

2008
[Hormonal contraception using depot preparations].
    Therapeutische Umschau. Revue therapeutique, 1986, Volume: 43, Issue:5

    Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk

1986

Other Studies

14 other study(ies) available for medroxyprogesterone acetate and Abnormalities, Drug-Induced

ArticleYear
MPA given orally during the first trimester for threatened miscarriage carries no specific risk for foetal abnormalities albeit the rate is higher than non-threatened pregnancies.
    Reproductive biology, 2020, Volume: 20, Issue:3

    Topics: Abnormalities, Drug-Induced; Abortion, Threatened; Adult; Female; Humans; Incidence; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Retrospective Studies

2020
THE EFFECT OF PROVERA ON THE FETUS.
    Obstetrics and gynecology, 1964, Volume: 23

    Topics: Abnormalities, Drug-Induced; Abortion, Induced; Drug Therapy; Female; Fetus; Humans; Infant, Newborn; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications; Pregnancy Complications, Hematologic; Pregnancy Tests; Toxicology; Uterine Hemorrhage; Virilism

1964
Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1982, Volume: 20, Issue:1

    Topics: Abnormalities, Drug-Induced; Birth Weight; Body Weight; Child, Preschool; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infections; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Postpartum Period; Pregnancy; Prenatal Exposure Delayed Effects

1982
Teratogenic effects of Silastic intrauterine devices in the rat with or without added medroxyprogesterone acetate.
    Fertility and sterility, 1983, Volume: 39, Issue:2

    Topics: Abnormalities, Drug-Induced; Animals; Contraceptive Agents, Female; Female; Genitalia, Female; Genitalia, Male; Intrauterine Devices; Intrauterine Devices, Medicated; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Rats; Rats, Inbred Strains; Silicone Elastomers

1983
[Real and false risks of injectable hormonal contraception].
    Gynakologische Rundschau, 1984, Volume: 24 Suppl 1

    Topics: Abnormalities, Drug-Induced; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Infant, Newborn; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Pregnancy; Risk

1984
Depo-Provera: a critical analysis.
    Women & health, 1980,Summer, Volume: 5, Issue:2

    Topics: Abnormalities, Drug-Induced; Animals; Breast Feeding; Contraceptive Agents, Female; Dogs; Female; Haplorhini; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Neoplasms; Pregnancy; United States; United States Food and Drug Administration; Uterine Neoplasms

1980
Teratogenic effects of cyproterone acetate and medroxyprogesterone treatment during the pre- and postimplantation period of mouse embryos. I.
    Teratology, 1982, Volume: 25, Issue:1

    Topics: Abnormalities, Drug-Induced; Animals; Cleft Palate; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Dose-Response Relationship, Drug; Embryonic Development; Female; Fetal Death; Gestational Age; Heart Defects, Congenital; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Pregnancy; Respiratory System Abnormalities; Skull; Urinary Tract

1982
Dismissal of wrongful birth action reversed. Canesi ex rel. Canesi v. Wilson.
    Hospital law newsletter, 2000, Volume: 17, Issue:3

    Topics: Abnormalities, Drug-Induced; Female; Humans; Infant, Newborn; Informed Consent; Liability, Legal; Malpractice; Medroxyprogesterone Acetate; New Jersey; Pregnancy; Risk; Wrongful Life

2000
Steroid contraceptive use and pregnancy outcome.
    Teratology, 1988, Volume: 38, Issue:1

    Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Humans; Maternal Age; Maternal-Fetal Exchange; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Risk Factors; Syndactyly; Thailand; Trisomy

1988
Embryotoxicity of a single dose of medroxyprogesterone acetate (MPA) and maternal serum MPA concentrations in cynomolgus monkey (Macaca fascicularis).
    Teratology, 1985, Volume: 32, Issue:3

    Topics: Abnormalities, Drug-Induced; Adrenal Glands; Animals; Dose-Response Relationship, Drug; Female; Genitalia; Heart Defects, Congenital; Macaca fascicularis; Male; Maternal-Fetal Exchange; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy

1985
Embryotoxicity and maternal serum concentrations of medroxyprogesterone acetate (MPA) in baboons (Papio cynocephalus).
    Contraception, 1985, Volume: 32, Issue:5

    Topics: Abnormalities, Drug-Induced; Animals; Female; Genitalia, Female; Genitalia, Male; Gestational Age; Male; Maternal-Fetal Exchange; Medroxyprogesterone; Medroxyprogesterone Acetate; Papio; Pregnancy; Teratogens

1985
Comments on two recent papers dealing with the teratogenicity of medroxyprogesterone acetate.
    Teratology, 1985, Volume: 31, Issue:2

    Topics: Abnormalities, Drug-Induced; Animals; Delayed-Action Preparations; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Pregnancy; Research Design

1985
Teratogenicity of progestogens given during the first trimester of pregnancy.
    Obstetrics and gynecology, 1985, Volume: 65, Issue:6

    Topics: Abnormalities, Drug-Induced; Abortion, Habitual; Adult; Anencephaly; Female; Heart Defects, Congenital; Hip Dislocation, Congenital; Humans; Hydrocephalus; Infant, Newborn; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Trimester, First; Spina Bifida Occulta

1985
Fetal abnormality (Goldenhar syndrome) occurring in one of triplet infants derived from in vitro fertilization with possible monozygotic twinning.
    Journal of in vitro fertilization and embryo transfer : IVF, 1985, Volume: 2, Issue:1

    Topics: Abnormalities, Drug-Induced; Female; Fertilization in Vitro; Goldenhar Syndrome; Humans; Infant, Newborn; Male; Mandibulofacial Dysostosis; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Triplets; Twins; Twins, Monozygotic

1985